Guggenheim analyst Steven Forbes trimmed estimates on Neutral-rated Bed Bath & Beyond (NASDAQ: BBBY) after Q2 results fell short ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE